,Pharmaceutical company,Gross margin
0,Novo Nordisk,82.6%
1,Amgen,81.3%
2,Biogen,81%
3,Gilead,79.1%
4,Lilly,78.8%
5,AbbVie,77.1%
6,AstraZenca,72.4%
7,Pfizer,71.5%
8,Roche,71.3%
9,Merck & Co.,70.2%
10,Novartis,69.6%
11,GlaxoSmithKline,67.8%
12,Johnson & Johnson,67%
13,Bristol-Myers Squibb,66%
14,Sanofi,60.5%
15,Endo,46.3%
16,Teva,44.6%
17,Mylan,36.4%
